Short-term eplerenone for treatment of chronic central serous chorioretinopathy; a prospective study

BACKGROUND: Increased mineralocorticoid activity is one of the plausible causes of chronic central serous chorioretinopathy (CSCR) and mineralocorticoid inhibitors such as eplerenone have been investigated as its potential therapy. This study investigates the short-term safety and efficacy of oral e...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Int J Retina Vitreous
Päätekijät: Moein, Hamid-Reza, Bierman, Lauren W., Novais, Eduardo A., Moreira-Neto, Carlos, Baumal, Caroline R., Rogers, Adam, Duker, Jay S., Witkin, André J.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2019
Aiheet:
Original Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6734298/
https://ncbi.nlm.nih.gov/pubmed/31516734
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40942-019-0190-y
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia